These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 35879545)
1. Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection. Cui Z; Zeng C; Huang F; Yuan F; Yan J; Zhao Y; Zhou Y; Hankey W; Jin VX; Huang J; Staats HF; Everitt JI; Sempowski GD; Wang H; Dong Y; Liu SL; Wang Q Nat Chem Biol; 2022 Oct; 18(10):1056-1064. PubMed ID: 35879545 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 receptor and malignant cancers: Association of Zhang L; Wei C; Li D; He J; Liu S; Deng H; Cheng J; Du J; Liu X; Chen H; Sun S; Yu H; Fu J Int J Biol Sci; 2022; 18(6):2362-2371. PubMed ID: 35414771 [TBL] [Abstract][Full Text] [Related]
3. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Zhao MM; Yang WL; Yang FY; Zhang L; Huang WJ; Hou W; Fan CF; Jin RH; Feng YM; Wang YC; Yang JK Signal Transduct Target Ther; 2021 Mar; 6(1):134. PubMed ID: 33774649 [TBL] [Abstract][Full Text] [Related]
4. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. Li K; Meyerholz DK; Bartlett JA; McCray PB mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553 [TBL] [Abstract][Full Text] [Related]
5. Dual Inhibitors of Main Protease (M Mondal S; Chen Y; Lockbaum GJ; Sen S; Chaudhuri S; Reyes AC; Lee JM; Kaur AN; Sultana N; Cameron MD; Shaffer SA; Schiffer CA; Fitzgerald KA; Thompson PR J Am Chem Soc; 2022 Nov; 144(46):21035-21045. PubMed ID: 36356199 [TBL] [Abstract][Full Text] [Related]
6. Olgotrelvir, a dual inhibitor of SARS-CoV-2 M Mao L; Shaabani N; Zhang X; Jin C; Xu W; Argent C; Kushnareva Y; Powers C; Stegman K; Liu J; Xie H; Xu C; Bao Y; Xu L; Zhang Y; Yang H; Qian S; Hu Y; Shao J; Zhang C; Li T; Li Y; Liu N; Lin Z; Wang S; Wang C; Shen W; Lin Y; Shu D; Zhu Z; Kotoi O; Kerwin L; Han Q; Chumakova L; Teijaro J; Royal M; Brunswick M; Allen R; Ji H; Lu H; Xu X Med; 2024 Jan; 5(1):42-61.e23. PubMed ID: 38181791 [TBL] [Abstract][Full Text] [Related]
7. Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection. Dampalla CS; Zheng J; Perera KD; Wong LR; Meyerholz DK; Nguyen HN; Kashipathy MM; Battaile KP; Lovell S; Kim Y; Perlman S; Groutas WC; Chang KO Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34210738 [TBL] [Abstract][Full Text] [Related]
8. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease. Kreutzberger AJB; Sanyal A; Ojha R; Pyle JD; Vapalahti O; Balistreri G; Kirchhausen T J Virol; 2021 Oct; 95(21):e0097521. PubMed ID: 34406858 [TBL] [Abstract][Full Text] [Related]
9. Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection. Padmanabhan P; Desikan R; Dixit NM PLoS Comput Biol; 2020 Dec; 16(12):e1008461. PubMed ID: 33290397 [TBL] [Abstract][Full Text] [Related]
12. Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization. Ciaglia T; Vestuto V; Di Sarno V; Musella S; Smaldone G; Di Matteo F; Napolitano V; Miranda MR; Pepe G; Basilicata MG; Novi S; Capolupo I; Bifulco G; Campiglia P; Gomez-Monterrey I; Snoeck R; Andrei G; Manfra M; Ostacolo C; Lauro G; Bertamino A Eur J Med Chem; 2024 Feb; 266():116128. PubMed ID: 38232463 [TBL] [Abstract][Full Text] [Related]
13. Nanoengineered Red Blood Cells Loaded with TMPRSS2 and Cathepsin L Inhibitors Block SARS-CoV-2 Pseudovirus Entry into Lung ACE2 Yang H; Zhou JN; Zhang XM; Ling DD; Sun YB; Li CY; Zhou QQ; Shi GN; Wang SH; Lin XS; Fan T; Wang HY; Zeng Q; Jia YL; Xi JF; Jin YG; Pei XT; Yue W Adv Mater; 2024 Apr; 36(15):e2310306. PubMed ID: 38194699 [TBL] [Abstract][Full Text] [Related]
14. Effects of vitamin C and D on the mRNA expression of angiotensin converting enzyme 2 receptor, cathepsin L, and transmembrane serine protease in the mouse lungs. A Alruwaili M; Jarrar Y Libyan J Med; 2022 Dec; 17(1):2054111. PubMed ID: 35311495 [TBL] [Abstract][Full Text] [Related]
15. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. Hoffmann M; Hofmann-Winkler H; Smith JC; Krüger N; Arora P; Sørensen LK; Søgaard OS; Hasselstrøm JB; Winkler M; Hempel T; Raich L; Olsson S; Danov O; Jonigk D; Yamazoe T; Yamatsuta K; Mizuno H; Ludwig S; Noé F; Kjolby M; Braun A; Sheltzer JM; Pöhlmann S EBioMedicine; 2021 Mar; 65():103255. PubMed ID: 33676899 [TBL] [Abstract][Full Text] [Related]
16. Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2. Li Y; Wang K; Sun H; Wu S; Wang H; Shi Y; Li X; Yan H; Yang G; Wu M; Li Y; Ding X; Si S; Jiang J; Du Y; Li Y; Hong B Antiviral Res; 2023 Jun; 214():105606. PubMed ID: 37076089 [TBL] [Abstract][Full Text] [Related]